{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T02:34:48Z","timestamp":1649212488366},"reference-count":93,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.bpobgyn.2011.11.002","type":"journal-article","created":{"date-parts":[[2012,2,22]],"date-time":"2012-02-22T05:16:57Z","timestamp":1329887817000},"page":"267-282","source":"Crossref","is-referenced-by-count":0,"title":["Screening for gynaecologic cancers in genetically predisposed women"],"prefix":"10.1016","volume":"26","author":[{"given":"Greta","family":"Dreyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2011.11.002_bib1","first-page":"265","article-title":"Breast and ovarian cancer incidence in BRCA1 mutation carriers","volume":"56","author":"Easton","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib3","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.20.5.1260","article-title":"Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers","volume":"20","author":"Scheuer","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib4","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1158\/1055-9965.EPI-09-0171","article-title":"Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent","volume":"18","author":"Evans","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng1294-399","article-title":"Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian carcinoma in ten families","volume":"8","author":"Friedman","year":"1994","journal-title":"Nature Genet"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1756-9966-29-82","article-title":"Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumour suppressor genes mutation detection","volume":"29","author":"Ibrahim","year":"2010","journal-title":"J Exper Clin Cancer Res"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib8","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1158\/1055-9965.EPI-07-0129","article-title":"Polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1\/2 Study","volume":"16","author":"Couch","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ijc.20186","article-title":"BRCA1 mutations in South African breast and\/or ovarian cancer families: evidence of a novel founder mutation in Afrikaner families","volume":"110","author":"Reeves","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.7196\/SAMJ.3235","article-title":"Cancer prevalence in 129 breast-ovarian cancer families tested for BRCA1 and BRCA2 mutations","volume":"100","author":"Schlebusch","year":"2010","journal-title":"S Afr Med J"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib11","first-page":"113","article-title":"BRCA1 and BRCA2 analysis of 208 Ashkenazi Jewish women with ovarian cancer","volume":"100","author":"Moslehi","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ajhg.2008.02.008","article-title":"Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutations carriers","volume":"82","author":"Antoniou","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/107327480901600103","article-title":"Endometrial cancer and Lynch syndrome: clinical and pathologic considerations","volume":"16","author":"Meyer","year":"2009","journal-title":"Cancer Control"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10689-008-9219-3","article-title":"High risk of endometrial cancer in colorectal cancer kindred is pathognomonic for MMR-mutation carriers","volume":"8","author":"Grindedal","year":"2009","journal-title":"Familial Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib15","first-page":"85","article-title":"Gynecologic manifestations of hereditary nonpolyposis colorectal cancer. From inherited to sporadic disease. [Review]","volume":"94","author":"Taylor","year":"2006","journal-title":"Oncology"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib16","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0016-5085(99)70510-X","article-title":"New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC","volume":"116","author":"Vasen","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1011590617833","article-title":"Cancer risk in mismatch repair gene mutation carriers","volume":"1","author":"Watson","year":"2001","journal-title":"Fam Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.critrevonc.2008.06.003","article-title":"Hereditary ovarian cancer","volume":"69","author":"Russo","year":"2009","journal-title":"Crit Review Oncol-Hematol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2011.11.002_bib19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/jmg.2003.017996","article-title":"Update on the Manchester Scoring System for BRCA1 and BRCA2 testing","volume":"41","author":"Evans","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1200\/JCO.2008.21.4684","article-title":"Preventing future cancers by testing women with ovarian cancer for BRCA mutations","volume":"28","author":"Kwon","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1148\/radiol.2302030360","article-title":"Screening-detected Breast Cancer in a Man with BRCA2 Mutation: Case Report","volume":"230","author":"Brenner","year":"2004","journal-title":"Radiol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib22","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.20.6.1480","article-title":"Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals","volume":"20","author":"Franks","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib23","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 and BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ijc.1627","article-title":"Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast\/ovarian cancer families: Implications for genetic testing","volume":"97","author":"Miguel","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2214\/AJR.09.3999","article-title":"Risk assessment and genetic testing for ovarian cancer. [Review]","volume":"194","author":"Gulden","year":"2010","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib26","unstructured":"Somer R, Farengo-Clark D, Patel A, et\u00a0al. Risk, Epidemiology and Prevention \u2013 Familial Breast Cancer \u2013 Genetic Testing Screening for BRCA1 Mutations in Patients with Triple Negative Breast Cancer and Basal Phenotype."},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10897-007-9090-7","article-title":"Risk assessment and genetic counselling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. [Review]","volume":"16","author":"Berliner","year":"2007","journal-title":"J Genet Counsel"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib28","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1093\/jnci\/89.23.1758","article-title":"A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and the Bethesda guidelines","volume":"89","author":"Rodriguez-Bigas","year":"1997","journal-title":"J Natl Cancer Instit"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer syndrome (Lynch syndrome) and microsatellite instability","volume":"96","author":"Umar","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib30","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1200\/JCO.2003.04.094","article-title":"Towards new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis","volume":"21","author":"Berends","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/jnci\/djp450","article-title":"Designing early detection programs for ovarian cancer","volume":"102","author":"Hartge","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib32","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1158\/0008-5472.CAN-06-1114","article-title":"Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer syndrome) among endometrial cancer patients","volume":"66","author":"Hampel","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib33","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/jjco\/hyq144","article-title":"Hereditary non-polyposis colorectal cancer\/Lynch syndrome in Korean patients with endometrial cancer","volume":"40","author":"Lim","year":"2010","journal-title":"Japan J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib34","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ygyno.2009.11.021","article-title":"Lynch syndrome among gynecologic oncology patients meeting the Bethesda guidelines for screening","volume":"116","author":"Walsh","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.2003.07.007","article-title":"Application of breast cancer risk prediction models in clinical practice","volume":"21","author":"Domchek","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib36","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/jnci\/djq088","article-title":"Assessing women at high risk of breast cancer: a review of risk assessment models","volume":"102","author":"Amir","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1471-0528.1998.tb10148.x","article-title":"A systematic review and meta-analysis of family history and risk of ovarian cancer","volume":"105","author":"Stratton","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib38","first-page":"35","article-title":"Family history of cancer and the risk of endometrial cancer","volume":"135","author":"Lucenteforte","year":"2009","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib39","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1158\/1055-9965.EPI-05-0687","article-title":"Breast and ovarian cancer in relatives of cancer patients with and without BRCA mutations","volume":"15","author":"Lee","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ng0197-103","article-title":"Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene","volume":"15","author":"Gayther","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib41","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10549-009-0528-5","article-title":"Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab)","volume":"120","author":"Kiely","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib42","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.ygyno.2006.06.032","article-title":"Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: a prospective cohort study","volume":"103","author":"Bosse","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib43","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/PAS.0b013e31819e986a","article-title":"Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma","volume":"33","author":"Rabban","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib44","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 and BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib45","first-page":"5420","article-title":"Modification of BRCA1- and BRCA2-associated breast cancer risk by AlB1 genotype and reproductive history","volume":"61","author":"Rebbeck","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib46","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ygyno.2004.09.039","article-title":"The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers","volume":"96","author":"Metcalfe","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib47","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/IGC.0b013e3181d7283a","article-title":"Contribution of ultrasonography to endometrial cancer screening in patients with hereditary nonpolyposis colorectal cancer\/Lynch syndrome","volume":"20","author":"L\u00e9curu","year":"2010","journal-title":"Intl J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib48","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/ejhg.2009.60","article-title":"Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary risk","volume":"17","author":"Evans","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib49","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(82)92681-2","article-title":"Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian cancer prone families","volume":"2","author":"Tobacman","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib50","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/IGC.0b013e3181a1b5dc","article-title":"High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy","volume":"19","author":"Hirst","year":"2009","journal-title":"Int J Gyn Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib51","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","article-title":"Cancer Incidence in BRCA1 Mutation Carriers","volume":"94","author":"Thompson","year":"2002","journal-title":"J Natl Inst"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1067\/mob.2002.119187","article-title":"Fallopian tube cancer in a BRCA1 mutation carrier: Rapid development and failure of screening","volume":"186","author":"Hebert-Blouin","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib53","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1006\/gyno.2000.5740","article-title":"Germline BRCA2 Mutation in a Patient with Fallopian Tube Carcinoma: A Case Report","volume":"77","author":"Rose","year":"2000","journal-title":"Gynaecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/gyno.1999.5623","article-title":"Molecular evidence linking primary cancer of the fallopian tube to BRCA1 mutations","volume":"76","author":"Zweemer","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib55","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ygyno.2003.08.018","article-title":"Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases","volume":"91","author":"Slomovitz","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib56","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1200\/jco.2007.25.18_suppl.5588","article-title":"Increased risk of cervical cancer in high-risk families with and without mutations in the BRCA1 and BRCA2 genes","volume":"25","author":"Rhiem","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib57","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0002-9378(98)70476-4","article-title":"BRCA1, BRCA2 and hereditary non polyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship with family history and implications for genetic testing","volume":"178","author":"Rubin","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib58","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1586\/14737140.8.7.1159","article-title":"Genetic polymorphisms and endometrial cancer risk","volume":"8","author":"Meyer","year":"2008","journal-title":"Expert Anticancer Ther"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib59","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2 and MSH6 genes in Lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib60","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jama.1997.03540350065035","article-title":"Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I Hereditary nopolyposis colon cancer. Cancer Genetics Studies Consortium","volume":"277","author":"Burke","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib61","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1200\/JCO.2007.10.8597","article-title":"Prospective determination of prevalence of Lynch syndrome in young women with endometrial cancer","volume":"25","author":"Lu","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib62","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/gyno.2001.6279","article-title":"The clinical features of ovarian cancer in hereditary nn-polyposis colon cancer","volume":"82","author":"Watson","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib63","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1053\/j.gastro.2010.06.061","article-title":"Frequent gastrointestinal polyps and colorectal adenocarcinoma in a prospective series of PTEN mutation carriers","volume":"139","author":"Heald","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib64","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/jmg.37.11.828","article-title":"Will the real Cowden syndrome please stand up: revised diagnositic criteria","volume":"37","author":"Eng","year":"2000","journal-title":"J Med Genet"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib65","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/AOG.0b013e31819cda77","article-title":"Results from four rounds of ovarian cancer screening in a randomized trial","volume":"113","author":"Partridge","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib66","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1470-2045(09)70026-9","article-title":"Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)","volume":"10","author":"Menon","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib67","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00008469-200508000-00014","article-title":"Use of intensified early cancer detection in high-risk patients with familial breast and ovarian cancer","volume":"14","author":"Lux","year":"2005","journal-title":"Europ J Cancer Prev"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib68","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/jnci\/djp438","article-title":"Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study","volume":"102","author":"Anderson","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib69","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1006\/gyno.2001.6253","article-title":"Three-dimensional power Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction","volume":"82","author":"Cohen","year":"2001","journal-title":"Gynaecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib70","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/IGC.0b013e3181b33c4a","article-title":"The counselling and management of young healthy BRCA mutation carriers","volume":"19","author":"Eitan","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib71","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2214\/AJR.09.3999","article-title":"Risk assessment and genetic testing for ovarian cancer","volume":"194","author":"Gulden","year":"2010","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib72","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1158\/1055-9965.EPI-07-2703","article-title":"A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study","volume":"17","author":"Greene","year":"2008","journal-title":"Cancer Epidemiol Biomark Prevent"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib73","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1701-2163(16)30294-8","article-title":"Ultrasonographic assessment of endometrial thickness: a review","volume":"24","author":"Persadie","year":"2002","journal-title":"J Obstet Gynecol Can"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib74","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/humrep\/deh567","article-title":"ATAC Tralists\u2019 Group. The ATAC adjuvant breat cancrer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy","volume":"20","author":"Duffy","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib75","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1701-2163(16)30643-0","article-title":"Screening postmenopausal women for ovarian cancer: a systematic review","volume":"26","author":"Fung","year":"2004","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib76","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2006.11.015","article-title":"Does a BRCA mutation plus tamoxifen equal hysterectomy?","volume":"104","author":"Lu","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib78","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study","volume":"90","author":"Fischer","year":"1998","journal-title":"J Natl Cancer Instit"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib79","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10897-009-9245-9","article-title":"Women\u2019s decision making about risk-reducing strategies in the context of hereditary breast and ovarian cancer: a systematic review","volume":"18","author":"Howard","year":"2009","journal-title":"J Genet Counsel"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib80","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10689-008-9208-6","article-title":"Use of total abdominal hysterectomy and hormone replacement therapy in BRCA1 and BRCA2 mutation carriers undergoing risk-reducing salpingo-oophorectomy","volume":"8","author":"Gabriel","year":"2009","journal-title":"Fam Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib81","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2007.09.031","article-title":"Society of Gynecologic Oncologists Educational Committee statement on risk assessment for inherited gynecologic cancer predispositions","volume":"107","author":"Lancaster","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib82","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/ijc.23340","article-title":"International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers","volume":"122","author":"Metcalfe","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib83","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0140-6736(96)05023-4","article-title":"Ovarian ablation in early breast cancer: overview of the randomised trials","volume":"348","author":"Early Breast Cancer Trialists \u2018Collaborative Group\u2019","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib84","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00008469-200512000-00003","article-title":"Age of uptake of early cancer detection facilities by low-risk and high-risk patients with familial breast and ovarian cancer","volume":"14","author":"Lux","year":"2005","journal-title":"Europ J Cancer Prevent"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib85","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/gyno.2000.6003","article-title":"Is uterine serous papillary adenocarcinoms a manifestation of the hereditary breast-ovarian cancer syndrome?","volume":"79","author":"Goshen","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib86","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10549-009-0476-0","article-title":"Physical activity and the risk of breast cancer in BRCA1\/2 mutation carriers","volume":"120","author":"Pijpe","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib87","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/ajmg.a.33068","article-title":"The process of deciding about prophylactic surgery for breast and ovarian cancer: Patient questions, uncertainties, and communication","volume":"152","author":"Klitzman","year":"2010","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib88","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1200\/JCO.2003.09.052","article-title":"Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast of ovarian cancer from families with a BRCA1 or BRCA2 mutation","volume":"21","author":"Meijers-Heijboer","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib89","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10689-009-9242-z","article-title":"Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting","volume":"8","author":"Morgan","year":"2009","journal-title":"Fam Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib90","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","article-title":"Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group","volume":"22","author":"Rebbeck","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib91","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10549-010-0868-1","article-title":"Predictors of breast cancer screening behaviour in women with a strong family history of the disease","volume":"124","author":"Price","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib92","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pec.2007.09.007","article-title":"Subjective and objective risk of ovarian cancer in Ashkehazi Jewish women testing for BRC1\/2 mutations","volume":"70","author":"Kelly","year":"2008","journal-title":"Patient Educ Counsel"},{"key":"10.1016\/j.bpobgyn.2011.11.002_bib93","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jmg.2007.056556","article-title":"Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring systems using data from UK genetics clinics","volume":"45","author":"Antoniou","year":"2008","journal-title":"J Med Genet"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693411001647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693411001647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T21:01:59Z","timestamp":1593723719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693411001647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1521693411001647"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2011.11.002","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}